RashidiAJhaveriKDWorkenehBT, et al. The path toward the creation of the American Society of Onco-Nephrology (ASON). J Onco-Nephrol. Epub ahead of print 8 March 2022. DOI: 10.1177/23993693221079647
2.
Launay-VacherVOudardSJanusN, et al; Renal Insufficiency and Cancer Medications (IRMA) Study Group. Prevalence of renal insufficiency in cancer patients and implications for anticancer drug management: the renal insufficiency and anticancer medications (IRMA) study. Cancer2007; 110(6): 1376–1384.
3.
CapassoABenigniACapitanioU, et al.; International Conference on Onco-Nephrology Participants. Summary of the International Conference on Onco-Nephrology: an emerging field in medicine. Kidney Int. 2019; 96(3):555–567.
4.
RousseauALafargueMCIsnard-BagnisC, et al. Renal failure and renal symptoms associated with molecular targeted therapies in oncology. Rev Prat. 2021; 71(2): 198–205.
5.
GuptaSShortSAPSiseME, et al.; ICPi-AKI Consortium Investigators. Acute kidney injury in patients treated with immune checkpoint inhibitors. J Immunother Cancer2021; 9(10): e003467.
